You are here

Andreas Schönenberger becomes new CEO of SIGVARIS AG

Andreas Schönenberger becomes new CEO of SIGVARIS AG

25. May 2014
The Board of Management of SIGVARIS Holding AG has appointed Andreas Schönenberger new CEO of SIGVARIS ECNE countries. Andreas Schönenberger will take over his new function on 1st June, 2014.

Andreas Schönenberger (*1962) graduated from the University of Basel with a degree in Economics and Social Science. In addition, he has completed different specialized trainings in Finance, Marketing and Communications. Andreas Schönenberger is currently Head of Consumer Health Care and member of the Board of Management at Sanofi Switzerland as well as member of the European Leadership team Consumer Healthcare. He previously served as Country Manager of Consumer Care at Bayer in Switzerland, as well as at Roche in Germany and Spain and as global Category Head at Bayer, USA. Andreas Schönenberger is married and father of four children.

Andreas Schönenberger has a relevant national and international functional and commercial background as well as a longstanding proven managing experience. In his former activities, he has greatly influenced success of different leading pharmaceutical companies.  

Mr. Schönenberger will take over his new function on June 1st, 2014.


Media Release

Press Photo

Media contact

SIGVARIS Management AG
Bettina Moosmann
Corporate Communications Manager
St. Georgenstrasse 70
8401 Winterthur

Phone: +41 52 265 00 81

About SIGVARIS - 150 years anniversary

SIGVARIS celebrated its 150th anniversary in 2014. The Swiss company can look back at a successful track record as it moves continuously towards the future, in keeping with its motto “Every day a step further”.

The Swiss company SIGVARIS, 100% family-owned since it was founded, is the global market leader in the manufacture of medical compression stockings. The company was established in 1864 in Winterthur. For around 100 years, SIGVARIS produced “rubber-elastic textiles”, which it sold both in Switzerland and abroad. From 1958 to 1960 the company collaborated with Dr. Karl Sigg to develop a medical compression stocking to improve venous function and relieve venous-related conditions. The product portfolio was expanded in 2009 when the WELL BEING and SPORTS lines were added to the main MEDICAL line. WELL BEING stockings have a preventive function and relieve the early symptoms of leg conditions while SPORTS products improve athlete performance and recovery time. Today SIGVARIS has 240 employees in Switzerland and its customers include pharmacies, chemists, orthopaedic and medical specialist stores as well as doctors and hospitals.


The Winterthur-based group has 1,400 employees worldwide and incorporates its own quality-guaranteed production plants in Switzerland, France, Brazil and the US as well as wholly-owned subsidiaries in Germany, Austria, UK, Canada, China, Australia, Mexico and the United Arab Emirates. These supply around 70 countries globally. SIGVARIS Group pursues an international growth strategy, which is driven by successful leverage of core competencies, strengthening of the WELL BEING and SPORTS lines and continuous expansion of its international presence. The Group produced about 8 million pairs of stockings in 2014 and generated revenue of around CHF 250 million.